Satış Değişiklik Tarih
argenx SE USD 1.72B 361M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Biogen USD 2.8B 60M 2026-09
Genmab DKK 1.16B 259M 2026-06
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
GRIFOLS EUR 2.04B 170M 2026-09
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Incyte USD 1.56B 110M 2026-09
Merck EUR 5.63B 200M 2026-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09
UCB EUR 4.25B 764M 2025-12
Vertex Pharmaceuticals USD 3.44B 110M 2026-09